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ABSTRACT
Introduction Health research using routinely col-
lected National Health Service (NHS) data derived
from electronic health records (EHRs) and health
service information systems has been growing in
both importance and quantity. Wide population
coverage and detailed patient-level information
allow this data to be applied to a variety of research
questions. However, the sensitivity, complexity and
scale of such data also hamper researchers from
fully exploiting this potential.
Objective Here, we establish the current challenges
preventing researchers frommaking optimal use of
the data sets at their disposal, on both the legislative
and practical levels, and give recommendations as
to how these challenges can be overcome.
Method A number of projects has recently been
launched in the UK to address poor research data-
management practices. RapidOrganisation ofHealth-
care Research Data (ROHRD) at Imperial College,
London produced a useful prototype that provides
local researchers with a one-stop index of available
data sets together with relevant metadata.
Findings Increased transparency of data sets’
availability and their provenance leads to better
utilisation and facilitates compliance with regulat-
ory requirements.
Discussion Research data resulting fromNHSdata
is often not utilised fully, or is handled in a hap-
hazard manner that prevents full auditability of the
research. Furthermore, lack of informatics and data
management skills in research teams act as a barrier
to implementing more advanced practices, such as
provenance capture and detailed, regularly updated,
data management strategies. Only by a concerted
eﬀort at the levels of research organisations, fund-
ing bodies and publishers, can we achieve full
transparency and reproducibility of the research.
Keywords: data governance, electronic health rec-
ords, open data, provenance
What is known about the subject
. The changing nature of data used in research studies from primary care data requires a shift towards secure
and traceable medical research.
. Current governance models and research practices in the UK are preventing optimal exploitation of
available data resources.
What this paper adds
. The legislative framework in the UK is at the root of governance issues faced by the research teams.
. Multiple initiatives in government are aiming to open up the health data for research in both academia and
industry.
. Home-grown research data management software is showing the way towards a more manageable and
secure sharing of data.
. Provenance of source data and research results is key to maintaining traceability of research.
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Introduction
The two core aspects of health research data manage-
ment are governance (who can access the data and to
what purpose) and provenance (where does the data
come from, and howwas it processed). Both permeate
each stage of the clinical research process, from data
collection, through cleaning, processing and analysis,
to publication and beyond. Changes to the regulatory
and software frameworks in research are currently
being introduced to recognise this and bring closer the
vision of secure and traceable medical research.
The need for standardisation in these two areas
is receiving increased attention. The Royal Society’s
June 2012 report Science as anOpen Enterprise, made a
number of recommendations about encouraging the
publishing and sharing of research data.1 In particular,
it stressed the need for capturing the provenance of
research data outputs, in terms of authorship, links to
relevant data sources and the data-processing history
of the presented results. Kush et al2 give an overview of
current eﬀorts in standardising research data from
electronic health records (EHRs), and many journals
are encouraging authors to publish their research data
along with their paper.3
Governance of research data
Each research data set has associated with it its own set
of information governance regulations, which vary
depending on the type of data, the presence of consent,
the relevant data controller and the parameters of
the data collection. For example, the Hospital Episode
Statistics (HES) protocol4 stipulates that HES data
must be held on isolated workstations, whereas
anonymised patient-level data from National Clinical
Audits (NCAs) may be held on secured internet-
connected servers. Some data sources diﬀerentiate
between conﬁdential (patient-identiﬁable) data and
sensitive data, with the latter typically consisting of
patients’ ethnicity, geographical information (some-
times including general practice location), political
and religious views, and criminal records. However,
the exact deﬁnition of these two classes of data is
variable, even for the data sources with the same
controller.5
Another anomaly is that geographic National
Health Service (NHS) data collected for clinical or
administrative purposes can be used without consent
for clinical audit and service evaluation, but not
always for research. However, most uses of this data
are for observational research, often indistinguishable
from service evaluation, but from a governance per-
spective this use is not diﬀerentiated from interven-
tional research such as clinical trials. For example,
general practices and NHS trusts are identiﬁed and
published in NCAs and other data sources such as the
Quality andOutcomes Framework (QOF), but are not
identiﬁable in some research data sets derived from
EHRs, preventing analysis of healthcare factors asso-
ciated with patient outcomes.
There is also no uniform guidance on when in the
analysis process the data may be removed from the
required secure environments to researchers’ desktops.
Is it when it has been stripped of sensitive data items,
or only when it has been aggregated? These unresolved
issues increase the likelihood of researchers inadver-
tently breaching data protection policies. Conversely,
they may also cause researchers to bury their data
inside isolated data silos within their institutions,
keeping it away not only from the outsiders, but also
from their peers who might be authorised to view it
and use it for their own research.6
The restrictive nature of the models that data
controllers currently employ is a direct consequence
of an ambiguous legislative framework. The Nuﬃeld
Trust has produced a useful summary of the back-
ground and implications of the current data protec-
tion models for health professionals and patients.7
Although as late as mid-1990s it was commonly
recognised that patient data should be freely available
for research, introduction of the Data Protection Act
in 1998 changed this. Despite provisions for secure
processing of identiﬁable data for medical research,
the exact deﬁnitions of ‘secure’ and ‘medical research’
were omitted, andmany data controllers chose to adopt
a strict interpretation of the rules that became known
as ‘consent or anonymise’, whereby either consent
should be obtained from each participant, or data was
fully anonymised at source, eﬀectively preventing any
linkage with other data sources.
Provisions for allowing linkage of patient-identiﬁ-
able data were introduced through Section 251 of the
NHS Act of 2006, when it became apparent that key
data sources such as cancer registrations would be
compromised bymore stringent legislation. Nonethe-
less, the process of obtaining the necessary permis-
sions for speciﬁc projects is still complex and time-
consuming, requiring application to the Ethics and
Conﬁdentiality Committee of the National Informa-
tion Governance Board for Health and Social Care,
whose functions will soon be taken over by the Health
Research Authority (HRA). Organisations such as the
NHS Information Centre for Health and Social Care
(NHSIC) have developed a business model by which
they handle this application process, acting as trusted
third parties, or safe havens, for linkage and deliver the
linked data to researchers.
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Opening the research landscape
in UK
The Open Data8 initiative aims to make publicly
generated data free and available to everyone, in useful
formats, subject to proper attribution. One part of
that vision, directly relevant to health data manage-
ment, is that any published research study should be
accompanied by the full data from which it was
derived, thus enabling the reader to verify the results
for themselves.
The government wants the United Kingdom (UK)
to become a world leader in the use of public data to
generate growth and expand knowledge.9 The Chan-
cellor of the Exchequer’s 2011 Autumn Statement set
out a range of Open Data measures to boost growth in
UK life sciences by transforming access to health
and care data.10 In response to this, NHSIC released
detailed general practice-level prescribing data online
for the ﬁrst time in September 201111 and in Sept-
ember 2012, it started a secure data linkage service to
deliver data extracts, using linked health record data
from primary and secondary care and other sources at
an unidentiﬁable, individual level.12
In summer 2012, the Prime Minister announced
that relaxing regulations on the collection and use of
patient data would help the UK to become the best
place in the world to conduct cutting-edge research.13
This will include amending the NHS Constitution to
enable patient data collected for clinical purposes to be
used for research unless patients opt out. To that goal,
a new secure data service, the Clinical Practice Re-
search Datalink (CPRD), has been established jointly
by the NIHR and the Medicines and Healthcare pro-
ducts Regulatory Agency (MHRA) to provide anon-
ymised linked data from general practice, HES and
other sources. The General Practice Extraction Service
(GPES) has also announced that it will start oﬀering
data from general practices, starting in April 2013.14
The data linkage with social survey data is helped by
the UK Data Archive, which makes freely available to
bona ﬁde researchers person-level survey data obtained
by informed consent. Similar eﬀorts are also present in
the USA, with federal government and private pro-
grammes that are dedicated to creating patient data-
bases for research, such as the Million Veterans
Program and the Kaiser Research Programme on
Genes, Environment and Health.
Discovery and usage of research
data
This wide availability of data brought to the forefront
initiatives to establish data registries within insti-
tutions and encourage data sharing, by facilitating
access and discovery. The Joint Information Systems
Committee (JISC) has been particularly supportive of
data-management initiatives in the UK, through its
support of the Digital Curation Centre, which aims to
build capacity, capability and skills for research data
management, as well as establishing a range of projects
in academic institutions under its Managing Research
Data stream.
One example of a JISC-funded project in this area is
the Rapid Organisation of Health Research Data
(ROHRD) project,15 which identiﬁed three key ob-
jectives for implementation of research data solutions:
. navigation of potentially vast data repositories
within and outside their institutions to ﬁnd the
data that satisﬁes researchers’ requirements
. quick and unambiguous retrieval of the data access
policies attached to that data
. uniform and eﬃcient process to obtain the data sets
themselves.
ROHRD delivered a metadata model to support the
ﬁrst two objectives. The model, implemented as an
ontology web language (OWL) ontology, uses the
SNOMED-CT clinical vocabulary,16 which is now a
standard clinical coding system for the NHS, and
captures contextual metadata about the data sets,
including content description, governance restric-
tions and access procedure. An example of a metadata
entry for one typical data set is given in Figure 1.
As a further step to support rapid visual querying of
the data set properties, ROHRD has implemented a
prototype web portal, linked from the metadata in-
formation that gives an interactive overview of age and
gender breakdowns, diagnostic code prevalence and
drug prescription frequencies, as shown in Figure 2.
Combined with the contextual and data governance
information, this framework gives researchers amech-
anism for data discovery.
Other similar initiatives include the Oxford
DataFlow17 and BRISSkit18 projects, which are cre-
ating a two-stage data management infrastructure to
enable researchers toworkwith, annotate, publish and
permanently store research data. The DataCite pro-
gramme,19 for which the British Library leads in the
UK, allows researchers to create unique digital object
identiﬁers (DOIs) for their data sets, so that they can
be published in the same way as journal articles. For
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example, following an outbreak of antibiotic-resistant
Escherichia coli in Germany in 2011, BGI-Shenzhen
included a DataCite DOI for the release of the genome
into the public domain.20
Provenance of research data sets
Traceability and accountability of research data are
essential components of data management in clinical
research, with standards such as GxP (including Good
ClinicalDataManagement Practice andGoodClinical
Practice), CONSORT for trial reporting, and STROBE
for reporting observational studies. Of particular
interest is ADAM21 produced by the Clinical Data
Interchange Standards Consortium (CDISC), which
documents each derived variable (treatment, outcome
or covariate) used in clinical trial analysis data sets, to
enable review and re-creation of published research.
The provenance of a piece of data refers to the
knowledge about its origin, in terms of the entities and
actors involved in its creation, e.g. data sources used,
Figure 1 Entry for a research data set represented using Imperial’s metadata ontology
Figure 2 Visual representation of drug code metadata for a data source
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operations carried out on them, together with the
users enacting those operations. In research data
management, provenance is concerned with both
the study source data, and the resulting data sets
produced. The former, source provenance, establishes
where data originated, including the patient popu-
lation proﬁle and the governance restrictions, whereas
the latter, transformational provenance, establishes the
data linkage and transformations, e.g. joins and ﬁlters
applied, performed on the source data to produce the
study results. Whereas source provenance is typically
manually entered and relatively small in size, trans-
formational provenance, which aims to capture every
operation applied to source data, can grow much
larger, and has to be captured automatically, using
software tools.
Making software systems provenance-aware en-
ables investigation of data sources and services that
produced a particular output from the software,
together with the individuals who instigated the re-
quests and received those outputs, to establish the
exact lineage and assess that correct procedures were
followed. The importance of provenance-aware infra-
structures is reﬂected in the increasing number of
biomedical research projects that include provenance
components, such as EU FP7’s TRANSFoRm22 and
EHR4CR.23
Provenance information is commonly represented
as causal graphs establishing relationships between
data entities, the processes that produced them and
the agents (researchers, computer software) that per-
formed those processes. The Open ProvenanceModel24
(OPM) is a popular community standard for prov-
enance description that is serving as a basis for the
oﬃcialWorldWideWebConsortiumPROV standard
currently in development.25 Provenance standards are
closely related to semantic web technologies, and are
based on uniform resource identiﬁers (URIs) for
element identiﬁcation, resource description frame-
work (RDF) and OWL ontologies. Usage of semantic
web technologies also enables the suitably annotated
provenance graphs to be easily queried using standard
medical ontologies, such as SNOMED-CT, ICD-10 or
Read codes. However, there are no formal standards
on the required level of provenance support in health
research.
Discussion
The importance of research data management is
increasingly recognised by both research funders and
journal publishers. The EU Commission, the UK’s
Medical Research Council and the US National Insti-
tute of Health are just some of the funding bodies that
now require research data management plans (RDMPs)
as part of funding applications. A useful overview of
the UK funders’ requirements is maintained by the
Digital Curation Centre.26 Major publishers are also
developing mechanisms, including data repositories
and research data set citation indices, to provide full
provenance of the data used for published research,
ensuring traceability and reproducibility.
This change is mirrored within research insti-
tutions, which are slowly abandoning local data silos,
and instead developing metadata registries, typically
as internal web portals, to collect information about
available data sets and their governance information,
and to establish access procedures. Such eﬀorts assist
in both regulatory compliance and full exploitation of
available data, but how these various initiatives will
evolve, and if they will converge, remains unclear.
This provenance-gathering continues in the studies
conducted with research data, with increasing num-
bers of software tools supporting automated prov-
enance capture, thereby documenting the analysis
steps, and facilitating complete research reporting.
However, many research groups are still relying on
non-standardised, fragmented software that is separated
from the overarching data management strategy,
disconnecting the ﬁndings from the processes that
produced them.
Software packages are now available that allow
research institutions to create their own data registries
and provenance-aware infrastructures with little ef-
fort,27,28 yet lack of research data management train-
ing, and of local data managers and informatics
specialists in medical research groups are hindering
progress. Key to overcoming this in a sustainable
manner is the creation of comprehensive health
informatics training programmes in the UK, includ-
ing research data management, at undergraduate and
postgraduate levels, focusing on data management,
information governance, software architectures and
semantic web technologies. Our key recommendations
for achieving this are given in Table 1.
Medical research is moving towards full trace-
ability, where data can be followed from its original
collection, via anonymisation and linkage, to the
analysis performed and the publication of results.
Essential to this vision is the opening of healthcare
data, through improved information governance
frameworks that make use of the current advances in
information technology. However, in order to sustain
the changes indicated by the various projects in the
area, there is a need for clearer and more consistent
policies, more trained data managers, software archi-
tects and semantic web specialists in medical research
groups.
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Table 1 Addressing the challenges of health research data management
Challenge Recommendation Stakeholders
Insuﬃcient incentive for
researchers to publish datasets
Academic funders and
institutions to add dataset
citation indices to research
excellence assessment, with clear




Governance models outdated and
too restrictive, with little or no
audit of adherence
More devolved approval process
for dataset usage needed, with
proactive approach by the Health
Research Authority, which is
taking over from National
Information Governance Board
Government, NHS
Lack of awareness of data
available to researchers within
institutions
Introduce metadata registries
where users can ﬁnd details on




Little or no provenance captured
during data analysis
Increase usage of provenance-
aware software tools and
middleware in standard research
practice, and incorporate it into
publication requirements
Academia, industry, publishers
Poor data management and lack
of coherent analytical software
strategy
Better health informatics training
and permanent data manager and
software architect positions in
health research groups
Academia, industry
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